231 related articles for article (PubMed ID: 18852383)
1. Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study.
Chirinos JA; David R; Bralley JA; Zea-Díaz H; Muñoz-Atahualpa E; Corrales-Medina F; Cuba-Bustinza C; Chirinos-Pacheco J; Medina-Lezama J
Hypertension; 2008 Dec; 52(6):1051-9. PubMed ID: 18852383
[TBL] [Abstract][Full Text] [Related]
2. Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study.
Notsu Y; Yano S; Shibata H; Nagai A; Nabika T
Atherosclerosis; 2015 Mar; 239(1):61-6. PubMed ID: 25576847
[TBL] [Abstract][Full Text] [Related]
3. Association between asymmetric dimethylarginine and indices of vascular function in patients with essential hypertension.
Serg M; Kampus P; Kals J; Zagura M; Muda P; Tuomainen TP; Zilmer K; Salum E; Zilmer M; Eha J
Blood Press; 2011 Apr; 20(2):111-6. PubMed ID: 21142418
[TBL] [Abstract][Full Text] [Related]
4. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure.
Nanayakkara PW; Teerlink T; Stehouwer CD; Allajar D; Spijkerman A; Schalkwijk C; ter Wee PM; van Guldener C
Kidney Int; 2005 Nov; 68(5):2230-6. PubMed ID: 16221223
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of l-arginine transport in platelets by asymmetric dimethylarginine and N-monomethyl-l-arginine: effects of arterial hypertension.
Brunini T; Moss M; Siqueira M; Meirelles L; Rozentul A; Mann G; Ellory J; Soares de Moura R; Mendes-Ribeiro A
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):738-40. PubMed ID: 15554917
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide synthase inhibitors and hypertension in children and adolescents.
Goonasekera CD; Rees DD; Woolard P; Frend A; Shah V; Dillon MJ
J Hypertens; 1997 Aug; 15(8):901-9. PubMed ID: 9280214
[TBL] [Abstract][Full Text] [Related]
7. Higher brachial-ankle pulse wave velocity is associated with more advanced carotid atherosclerosis in end-stage renal disease.
Munakata M; Sakuraba J; Tayama J; Furuta T; Yusa A; Nunokawa T; Yoshinaga K; Toyota T
Hypertens Res; 2005 Jan; 28(1):9-14. PubMed ID: 15969249
[TBL] [Abstract][Full Text] [Related]
8. Contribution of nitric oxide to the blood pressure and arterial responses to exercise in humans.
Campbell R; Fisher JP; Sharman JE; McDonnell BJ; Frenneaux MP
J Hum Hypertens; 2011 Apr; 25(4):262-70. PubMed ID: 20505750
[TBL] [Abstract][Full Text] [Related]
9. Effects of inhibition of basal nitric oxide synthesis on carotid-femoral pulse wave velocity and augmentation index in humans.
Stewart AD; Millasseau SC; Kearney MT; Ritter JM; Chowienczyk PJ
Hypertension; 2003 Nov; 42(5):915-8. PubMed ID: 12975386
[TBL] [Abstract][Full Text] [Related]
10. Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension.
Kielstein JT; Bode-Böger SM; Hesse G; Martens-Lobenhoffer J; Takacs A; Fliser D; Hoeper MM
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1414-8. PubMed ID: 15860741
[TBL] [Abstract][Full Text] [Related]
11. The Association between Nitric Oxide Pathway, Blood Pressure Abnormalities, and Cardiovascular Risk Profile in Pediatric Chronic Kidney Disease.
Hsu CN; Lu PC; Lo MH; Lin IC; Tain YL
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653115
[TBL] [Abstract][Full Text] [Related]
12. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
Antoniades C; Shirodaria C; Leeson P; Antonopoulos A; Warrick N; Van-Assche T; Cunnington C; Tousoulis D; Pillai R; Ratnatunga C; Stefanadis C; Channon KM
Eur Heart J; 2009 May; 30(9):1142-50. PubMed ID: 19297385
[TBL] [Abstract][Full Text] [Related]
13. Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men.
Ochiai M; Hayashi T; Morita M; Ina K; Maeda M; Watanabe F; Morishita K
Int J Cardiol; 2012 Mar; 155(2):257-61. PubMed ID: 21067832
[TBL] [Abstract][Full Text] [Related]
14. Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort.
Maas R; Xanthakis V; Polak JF; Schwedhelm E; Sullivan LM; Benndorf R; Schulze F; Vasan RS; Wolf PA; Böger RH; Seshadri S
Stroke; 2009 Aug; 40(8):2715-9. PubMed ID: 19498184
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric dimethylarginine and hemodynamic regulation in middle-aged men.
Päivä H; Laakso J; Kähönen M; Turjanmaa V; Kööbi T; Majahalme S; Lehtimäki T; Ruokonen I; Laaksonen R
Metabolism; 2006 Jun; 55(6):771-7. PubMed ID: 16713437
[TBL] [Abstract][Full Text] [Related]
16. Effect of systemic nitric oxide synthase inhibition on arterial stiffness in humans.
Sugawara J; Komine H; Hayashi K; Yoshizawa M; Yokoi T; Otsuki T; Shimojo N; Miyauchi T; Maeda S; Tanaka H
Hypertens Res; 2007 May; 30(5):411-5. PubMed ID: 17587753
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthesis capacity, ambulatory blood pressure and end organ damage in a black and white population: the SABPA study.
Mels CMC; Loots I; Schwedhelm E; Atzler D; Böger RH; Schutte AE
Amino Acids; 2016 Mar; 48(3):801-810. PubMed ID: 26573539
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric dimethylarginine and vascular indices of atherosclerosis in patients after coarctation of aorta repair.
Mizia-Stec K; Trojnarska O; Szczepaniak-Chicheł L; Gabriel M; Bartczak A; Ciepłucha A; Chudek J; Grajek S; Tykarski A; Gąsior Z
Int J Cardiol; 2012 Jul; 158(3):364-9. PubMed ID: 21334083
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease.
Liu X; Xu X; Shang R; Chen Y
Nitric Oxide; 2018 Aug; 78():113-120. PubMed ID: 29928990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
